CTRI/2023/10/059139尚未招募1/2 期
A randomized controlled clinical trial to evaluate the efficacy of Anutaila Nasya and Azelastine Nasal Spray in management of Vataj Pratishyaya.
PDEAs College Of Ayurved And Research Centre1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2023年10月11日最近更新:
试验速览
- 阶段
- 1/2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 56
- 试验地点
- 1
- 主要终点
- Sample Size 56 Decrease in sneezing,nasal obstruction, watery rhinorrhea and headache.
研究概览
简要总结
The study will be intervened by the treatment of Anutaila nasya and Azelastine nasal spray to group A and group B respectively. The efficacy of the therapy will be assessed on the basis of subjective criteria for statistical analysis. Scoring will be designed according to the severity of the symptoms. The subjective gradation of symptoms will be done as folllows and the intensity of each symptom will be calculated before treatment after treatment and after follow up. The signs and symptoms will be assessed by proper scoring method.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients diagnosed with Vataj Pratishyaya showing minimum three sign and syptoms like Nasastrav, Kshvathu, Nasaavrodh, Pihit nasa and Shirshool.
- •Age from 18 to 60 will be selected irrespective of sex, socioeconomic status and religion.
- •Patient Arah for nasya Patients ready to give written consent for trial and take part in the process of research.
排除标准
- •Patients with vasomotor rhinitis, acute infective rhinitis, atrophic rhinitis, rhinitis sicca, hypertrophic rhinitis.
- •Patients having severe systemic illness Patients who require surgical interventions Patients not willing for clinical trial Patients having associated illness Bronchial Asthma.
- •Patient Anarah for Nasya.
- •Patients having complaints of complete or bilateral nasal obstruction.
结局指标
主要结局
Sample Size 56 Decrease in sneezing,nasal obstruction, watery rhinorrhea and headache.
时间窗: Sample Size 56 Decrease in sneezing,nasal obstruction, watery rhinorrhea and headache in 2 weeks.
次要结局
- Decrease in sneezing,nasal obstruction, watery rhinorrhea and headache.(3 months)
研究者
研究点 (1)
Loading locations...
相似试验
撤回
1 期
Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of GlioblastomaGliosarcomaAnaplastic GliomasRecurrent GlioblastomaNCT03275558Center Trials & Treatment
已完成
早期 1 期
Study of a Topical Nasal Spray to Ease the Symptoms of HayfeverRhinitis, Allergic, SeasonalNCT01500629McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.21
已完成
3 期
A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In PediatricsRhinitis, Allergic, PerennialNCT00116883GlaxoSmithKline90
已完成
3 期
A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and AdultsRhinitis, Allergic, PerennialNCT00116818GlaxoSmithKline90
已完成
3 期
Study In Adults And Adolescents With Seasonal Allergic RhinitisHayfeverRhinitis, Allergic, SeasonalSeasonal Allergic RhinitisNCT00115622GlaxoSmithKline304